Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company […]
Bitcoin Depot Completes Purchase of Roughly 400 Additional Bitcoin ATMs for Q1 2024 Expansion
ATLANTA, Feb. 13, 2024 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM […]
Sirios Initiates Drilling in Cheechoo’s High-Grade Eclipse Gold Area
MONTREAL, Feb. 13, 2024 (GLOBE NEWSWIRE) — Management of Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) are pleased to announce […]
SONORO GOLD ANNOUNCES REVISED $1 MILLION PRIVATE PLACEMENT
“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN […]
H&R Block to Release “Responsibility Island,” a Reality TV Parody Series That Blends Comedy, Love and Taxes
KANSAS CITY, Mo., Feb. 13, 2024 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB), the company that revolutionized the tax services […]
Textainer Group Holdings Limited Reports Fourth-Quarter and Full-Year 2023 Results and Declares Dividend
HAMILTON, Bermuda, Feb. 13, 2024 (GLOBE NEWSWIRE) — Textainer Group Holdings Limited (NYSE: TGH; JSE: TXT) (“Textainer”, “the Company”, “we” […]
Collective Metals finds High Priority Targets at the Lamont Ridge-Findlay Target on its Princeton Property
Highlights Results from 2023 Phase II soil-sampling program identified multiple porphyry-style Cu-Mo-Au soil anomalies at Lamont Ridge Results interpreted to […]
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the […]
Navios Maritime Partners L.P. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2023
Revenue: $ 327.3 million for Q4 2023 $1,306.9 million for FY 2023 Net Income: $ 132.4 million for Q4 2023 $ 433.6 million […]
TSX News -
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™
TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a […]
